Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission
Blood (2013)
  • Roland B. Walter, Fred Hutchinson Cancer Research Center
  • Sarah A. Buckley, University of Washington
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Brent L. Wood, University of Washington
  • Barry E. Storer, Fred Hutchinson Cancer Research Center
  • Brenda M. Sandmaier, Fred Hutchinson Cancer Research Center
  • Min Fang, Fred Hutchinson Cancer Research Center
  • Boglarka Gyurkocza, Fred Hutchinson Cancer Research Center
  • Colleen Delaney, Fred Hutchinson Cancer Research Center
  • Jerald P. Radich, Fred Hutchinson Cancer Research Center
  • Elihu H. Estey, Fred Hutchinson Cancer Research Center
  • Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
September 5, 2013
DOI
10.1182/blood-2013-06-506725
Citation Information
Roland B. Walter, Sarah A. Buckley, John M. Pagel, Brent L. Wood, et al.. "Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission" Blood Vol. 122 Iss. 10 (2013) p. 1813 - 1821
Available at: http://works.bepress.com/john-pagel/126/